Senior Executive Service Performance Review Board, 50630 [2022-17657]
Download as PDF
<![CDATA[
50630
Federal Register / Vol. 87, No. 158 / Wednesday, August 17, 2022 / Notices
established in the last few decades;
however, FDA has become aware of an
increase in the number of adverse event
reports related to the misuse of these
products. These reports led FDA to
convene a meeting of the Ophthalmic
Devices Panel of the Medical Devices
Advisory Committee and the Risk
Communication Advisory Committee on
March 17, 2017, to discuss additional
measures to mitigate the potential risk
for misuse of these devices. The meeting
covered a range of important issues,
including appropriate labeling and
packaging of these products and the
importance of clearly communicating
these concerns to the consumer public,
which were incorporated into this draft
guidance. When finalized, this guidance
is intended to provide recommendations
concerning the content and format of
labeling for HPCPs. FDA believes that
the labeling recommendations in this
guidance may help manufacturers
develop labeling with information about
specific risks and directions for use of
the HPCPs in conjunction with a user’s
prescribed contact lenses.
This draft guidance is being issued
consistent with FDA’s good guidance
II. Electronic Access
Persons interested in obtaining a copy
of the draft guidance may do so by
downloading an electronic copy from
the internet. A search capability for all
Center for Devices and Radiological
Health guidance documents is available
at https://www.fda.gov/medical-devices/
device-advice-comprehensiveregulatory-assistance/guidancedocuments-medical-devices-andradiation-emitting-products. This
guidance document is also available at
https://www.regulations.gov or https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents.
Persons unable to download an
electronic copy of ‘‘Hydrogen PeroxideBased Contact Lens Care Products:
Consumer Labeling Recommendations—
Premarket Notification (510(k))
Submissions’’ may send an email
request to CDRH-Guidance@fda.hhs.gov
to receive an electronic copy of the
document. Please use the document
number 18041 and complete title to
identify the guidance you are
requesting.
III. Paperwork Reduction Act of 1995
While this guidance contains no new
collection of information, it does refer to
previously approved FDA collections of
information. Therefore, clearance by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995 (PRA) (44 U.S.C. 3501–
3521) is not required for this guidance.
The previously approved collections of
information are subject to review by
OMB under the PRA. The collections of
information in the following FDA
regulations, guidance, and forms have
been approved by OMB as listed in the
following table:
OMB control
No.
21 CFR part
Topic
807, subpart E ............................................................................
800, 801, and 809 ......................................................................
Premarket notification .................................................................
Medical Device Labeling Regulations ........................................
Dated: August 11, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2022–17642 Filed 8–16–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Senior Executive Service Performance
Review Board
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
ACTION:
Notice.
HRSA, an operating division
of HHS, is publishing a list of
individuals who may be named to serve
on the Senior Executive Service
Performance Review Board that oversees
the evaluation of performance
appraisals for Senior Executive Service
members for the Fiscal Years 2022 and
2023.
SUMMARY:
JSPEARS on DSK121TN23PROD with NOTICES
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the current thinking of FDA
on ‘‘Hydrogen Peroxide-Based Contact
Lens Care Products: Consumer Labeling
Recommendations—Premarket
Notification (510(k)) Submissions.’’ It
does not establish any rights for any
person and is not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations.
VerDate Sep<11>2014
17:22 Aug 16, 2022
Jkt 256001
Georgia Lyons, HRSA Executive
Resources, Office of Human Resources,
5600 Fishers Lane, Rm 12N06C,
Rockville, Maryland 20857, or (301)
443–4618.
SUPPLEMENTARY INFORMATION: Title 5,
U.S.C. Section 4314(c)(4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following individuals may be
named to serve on the Senior Executive
Service Performance Review Board:
Onyekachukwu Anaedozie
Anthony Archeval
Cynthia Baugh
Tonya Bowers
Adriane Burton
Tina Cheatham
Laura Cheever
Christopher Coppenbarger
Natasha Coulouris
Cheryl Dammons
Elizabeth DeVoss
Tanette Downs
Diana Espinosa
Catherine Ganey
Alexandra Garcia
Jordan Grossman
Heather Hauck
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
0910–0120
0910–0485
Alexandra Huttinger
Carole Johnson
Laura Kavanagh
Martin Kramer
James Macrae
Maren McBride Kahn
Susan Monarez
Thomas Morris
Suma Nair
Luis Padilla
Nisha Patel
Krista Pedley
Wendy Ponton
Sheila Pradia Williams
Michael Warren
Carole Johnson,
Administrator.
[FR Doc. 2022–17657 Filed 8–16–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 87, Number 158 (Wednesday, August 17, 2022)]
[Notices]
[Page 50630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17657]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Senior Executive Service Performance Review Board
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: HRSA, an operating division of HHS, is publishing a list of
individuals who may be named to serve on the Senior Executive Service
Performance Review Board that oversees the evaluation of performance
appraisals for Senior Executive Service members for the Fiscal Years
2022 and 2023.
FOR FURTHER INFORMATION CONTACT: Georgia Lyons, HRSA Executive
Resources, Office of Human Resources, 5600 Fishers Lane, Rm 12N06C,
Rockville, Maryland 20857, or (301) 443-4618.
SUPPLEMENTARY INFORMATION: Title 5, U.S.C. Section 4314(c)(4) of the
Civil Service Reform Act of 1978, Public Law 95-454, requires that the
appointment of Performance Review Board Members be published in the
Federal Register. The following individuals may be named to serve on
the Senior Executive Service Performance Review Board:
Onyekachukwu Anaedozie
Anthony Archeval
Cynthia Baugh
Tonya Bowers
Adriane Burton
Tina Cheatham
Laura Cheever
Christopher Coppenbarger
Natasha Coulouris
Cheryl Dammons
Elizabeth DeVoss
Tanette Downs
Diana Espinosa
Catherine Ganey
Alexandra Garcia
Jordan Grossman
Heather Hauck
Alexandra Huttinger
Carole Johnson
Laura Kavanagh
Martin Kramer
James Macrae
Maren McBride Kahn
Susan Monarez
Thomas Morris
Suma Nair
Luis Padilla
Nisha Patel
Krista Pedley
Wendy Ponton
Sheila Pradia Williams
Michael Warren
Carole Johnson,
Administrator.
[FR Doc. 2022-17657 Filed 8-16-22; 8:45 am]
BILLING CODE 4165-15-P
